Insilico Medicine announced that the inhalation f
Author: Michael
Alector confirmed it will discontinue the Phase 2
Stealth provided a commercial and research update
Renibus announced that data from the Phase 3 PROT
Deal strengthens cyclodextrin IP targeting ApoE4
A new obesity approach targets fat storage pathw
Sana and Mayo Clinic partner to advance a potent
Metashape Pharma announced that new preclinical d
VectorY Therapeutics has received authorization f
Leading experts warn that ageism and outdated bu